Co-Authors
This is a "connection" page, showing publications co-authored by Michael Stechman and Arturo Vilches-Moraga.
Connection Strength
0.809
-
Increased care at discharge from COVID-19: The association between pre-admission frailty and increased care needs after hospital discharge; a multicentre European observational cohort study. BMC Med. 2020 12 18; 18(1):408.
Score: 0.230
-
Multiple house occupancy is associated with mortality in hospitalized patients with COVID-19. Eur J Public Health. 2022 02 01; 32(1):133-139.
Score: 0.124
-
The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021 05 17; 50(2):420-429.
Score: 0.059
-
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19. Ther Adv Drug Saf. 2021; 12:2042098620985690.
Score: 0.058
-
The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19. Int J Cardiol Heart Vasc. 2020 Dec; 31:100660.
Score: 0.057
-
Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational study. BMJ Open. 2020 09 29; 10(9):e040569.
Score: 0.057
-
The Clinical Frailty Scale: Estimating the Prevalence of Frailty in Older Patients Hospitalised with COVID-19. The COPE Study. Geriatrics (Basel). 2020 Sep 21; 5(3).
Score: 0.056
-
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med. 2020 Aug 10; 9(8).
Score: 0.056
-
Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople). J Hosp Infect. 2020 Oct; 106(2):376-384.
Score: 0.056
-
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020 08; 5(8):e444-e451.
Score: 0.056